Diagnostic Challenges in Soft Tissue and Bone Pathology

COURSE DESCRIPTION

The diagnosis of soft tissue and bone tumors can be a significant challenge (even for experienced pathologists) because of their rarity, the broad morphological spectrum of mesenchymal tumors, and overlap with other soft tissue tumors and non-mesenchymal neoplasms. The discovery of specific immunohistochemical markers and molecular genetic alterations drives the evolution of soft tissue tumor classification. If you are a surgical pathologist who struggles with accurate diagnosis of these challenging neoplasms, this is the course for you! Learn from experts in an intimate mentoring environment that simulates clinical sign out. The venue for interactive microscopy is exceptional, and Palm Springs in the winter is a premiere resort destination.

COURSE OBJECTIVES

•  Refine skills in diagnosing a wide range of soft tissue and bone tumors
•  Select appropriate panels of immunohistochemical markers for soft tissue and bone tumors
•  Enhance interpretation of results of molecular genetic studies in the context of histology
of soft tissue and bone tumors

The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this live activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Registrants must take and pass the post-test in order to claim SAMs credit. Physicians can earn a maximum of 12 SAM credit hours.